Lennar Corporation (LEN-B) Stock Competitors & Peer Comparison
See (LEN-B) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LEN-B | $90.88 | +2.08% | 23B | 13.07 | $6.95 | +2.16% |
| DHI | $151.07 | +4.71% | 42.8B | 14.19 | $10.65 | +1.16% |
| LEN | $92.56 | +2.01% | 23.4B | 13.32 | $6.95 | +2.16% |
| PHM | $122.78 | +4.31% | 23.4B | 11.88 | $10.34 | +0.78% |
| NVR | $6,406.57 | +3.48% | 17.3B | 15.70 | $409.28 | N/A |
| TOL | $144.14 | +5.09% | 13.5B | 10.96 | $13.15 | +0.70% |
| TMHC | $71.64 | +0.28% | 6.7B | 10.68 | $6.71 | N/A |
| IBP | $206.03 | +2.90% | 5.6B | 22.03 | $9.35 | +1.61% |
| MTH | $72.09 | +5.64% | 4.8B | 13.16 | $5.48 | +2.46% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
Stock Comparison
LEN-B vs DHI Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, DHI has a market cap of 42.8B. Regarding current trading prices, LEN-B is priced at $90.88, while DHI trades at $151.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas DHI's P/E ratio is 14.19. In terms of profitability, LEN-B's ROE is +0.08%, compared to DHI's ROE of +0.13%. Regarding short-term risk, LEN-B is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check DHI's competition here
LEN-B vs LEN Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, LEN has a market cap of 23.4B. Regarding current trading prices, LEN-B is priced at $90.88, while LEN trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas LEN's P/E ratio is 13.32. In terms of profitability, LEN-B's ROE is +0.08%, compared to LEN's ROE of +0.08%. Regarding short-term risk, LEN-B is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LEN's competition here
LEN-B vs PHM Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, PHM has a market cap of 23.4B. Regarding current trading prices, LEN-B is priced at $90.88, while PHM trades at $122.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas PHM's P/E ratio is 11.88. In terms of profitability, LEN-B's ROE is +0.08%, compared to PHM's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check PHM's competition here
LEN-B vs NVR Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, NVR has a market cap of 17.3B. Regarding current trading prices, LEN-B is priced at $90.88, while NVR trades at $6,406.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas NVR's P/E ratio is 15.70. In terms of profitability, LEN-B's ROE is +0.08%, compared to NVR's ROE of +0.33%. Regarding short-term risk, LEN-B is more volatile compared to NVR. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NVR's competition here
LEN-B vs TOL Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, TOL has a market cap of 13.5B. Regarding current trading prices, LEN-B is priced at $90.88, while TOL trades at $144.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas TOL's P/E ratio is 10.96. In terms of profitability, LEN-B's ROE is +0.08%, compared to TOL's ROE of +0.15%. Regarding short-term risk, LEN-B is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check TOL's competition here
LEN-B vs TMHC Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, TMHC has a market cap of 6.7B. Regarding current trading prices, LEN-B is priced at $90.88, while TMHC trades at $71.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas TMHC's P/E ratio is 10.68. In terms of profitability, LEN-B's ROE is +0.08%, compared to TMHC's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to TMHC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TMHC's competition here
LEN-B vs IBP Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, IBP has a market cap of 5.6B. Regarding current trading prices, LEN-B is priced at $90.88, while IBP trades at $206.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas IBP's P/E ratio is 22.03. In terms of profitability, LEN-B's ROE is +0.08%, compared to IBP's ROE of +0.37%. Regarding short-term risk, LEN-B and IBP have similar daily volatility (3.46).Check IBP's competition here
LEN-B vs MTH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, MTH has a market cap of 4.8B. Regarding current trading prices, LEN-B is priced at $90.88, while MTH trades at $72.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas MTH's P/E ratio is 13.16. In terms of profitability, LEN-B's ROE is +0.08%, compared to MTH's ROE of +0.07%. Regarding short-term risk, LEN-B is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check MTH's competition here
LEN-B vs MDC Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, LEN-B is priced at $90.88, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas MDC's P/E ratio is 11.91. In terms of profitability, LEN-B's ROE is +0.08%, compared to MDC's ROE of +0.02%. Regarding short-term risk, LEN-B is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MDC's competition here
LEN-B vs CVCO Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, CVCO has a market cap of 4.4B. Regarding current trading prices, LEN-B is priced at $90.88, while CVCO trades at $578.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas CVCO's P/E ratio is 24.13. In terms of profitability, LEN-B's ROE is +0.08%, compared to CVCO's ROE of +0.18%. Regarding short-term risk, LEN-B is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check CVCO's competition here
LEN-B vs SKY Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, SKY has a market cap of 4.3B. Regarding current trading prices, LEN-B is priced at $90.88, while SKY trades at $77.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas SKY's P/E ratio is 21.21. In terms of profitability, LEN-B's ROE is +0.08%, compared to SKY's ROE of +0.13%. Regarding short-term risk, LEN-B is less volatile compared to SKY. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SKY's competition here
LEN-B vs TPH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, LEN-B is priced at $90.88, while TPH trades at $46.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas TPH's P/E ratio is 22.36. In terms of profitability, LEN-B's ROE is +0.08%, compared to TPH's ROE of +0.06%. Regarding short-term risk, LEN-B is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TPH's competition here
LEN-B vs MHO Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, MHO has a market cap of 3.6B. Regarding current trading prices, LEN-B is priced at $90.88, while MHO trades at $140.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas MHO's P/E ratio is 10.58. In terms of profitability, LEN-B's ROE is +0.08%, compared to MHO's ROE of +0.11%. Regarding short-term risk, LEN-B is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check MHO's competition here
LEN-B vs KBH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, KBH has a market cap of 3.3B. Regarding current trading prices, LEN-B is priced at $90.88, while KBH trades at $53.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas KBH's P/E ratio is 10.32. In terms of profitability, LEN-B's ROE is +0.08%, compared to KBH's ROE of +0.09%. Regarding short-term risk, LEN-B is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check KBH's competition here
LEN-B vs GRBK Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, GRBK has a market cap of 3.1B. Regarding current trading prices, LEN-B is priced at $90.88, while GRBK trades at $71.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas GRBK's P/E ratio is 10.51. In terms of profitability, LEN-B's ROE is +0.08%, compared to GRBK's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check GRBK's competition here
LEN-B vs HOVNP Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, HOVNP has a market cap of 3B. Regarding current trading prices, LEN-B is priced at $90.88, while HOVNP trades at $20.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas HOVNP's P/E ratio is -8.25. In terms of profitability, LEN-B's ROE is +0.08%, compared to HOVNP's ROE of +0.04%. Regarding short-term risk, LEN-B is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOVNP's competition here
LEN-B vs GRBK-PA Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, GRBK-PA has a market cap of 2.9B. Regarding current trading prices, LEN-B is priced at $90.88, while GRBK-PA trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas GRBK-PA's P/E ratio is 5.08. In terms of profitability, LEN-B's ROE is +0.08%, compared to GRBK-PA's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to GRBK-PA. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check GRBK-PA's competition here
LEN-B vs CCS Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, CCS has a market cap of 1.7B. Regarding current trading prices, LEN-B is priced at $90.88, while CCS trades at $58.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas CCS's P/E ratio is 13.10. In terms of profitability, LEN-B's ROE is +0.08%, compared to CCS's ROE of +0.05%. Regarding short-term risk, LEN-B is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check CCS's competition here
LEN-B vs DFH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, DFH has a market cap of 1.4B. Regarding current trading prices, LEN-B is priced at $90.88, while DFH trades at $14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas DFH's P/E ratio is 8.67. In terms of profitability, LEN-B's ROE is +0.08%, compared to DFH's ROE of +0.11%. Regarding short-term risk, LEN-B is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check DFH's competition here
LEN-B vs LGIH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, LGIH has a market cap of 1.2B. Regarding current trading prices, LEN-B is priced at $90.88, while LGIH trades at $53.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas LGIH's P/E ratio is 17.52. In terms of profitability, LEN-B's ROE is +0.08%, compared to LGIH's ROE of +0.03%. Regarding short-term risk, LEN-B is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LGIH's competition here
LEN-B vs BZH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, BZH has a market cap of 739.1M. Regarding current trading prices, LEN-B is priced at $90.88, while BZH trades at $27.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas BZH's P/E ratio is -150.22. In terms of profitability, LEN-B's ROE is +0.08%, compared to BZH's ROE of -0.00%. Regarding short-term risk, LEN-B is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check BZH's competition here
LEN-B vs LEGH Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, LEGH has a market cap of 590.5M. Regarding current trading prices, LEN-B is priced at $90.88, while LEGH trades at $24.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas LEGH's P/E ratio is 14.03. In terms of profitability, LEN-B's ROE is +0.08%, compared to LEGH's ROE of +0.08%. Regarding short-term risk, LEN-B is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LEGH's competition here
LEN-B vs HOV Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, HOV has a market cap of 577M. Regarding current trading prices, LEN-B is priced at $90.88, while HOV trades at $114.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas HOV's P/E ratio is 31.51. In terms of profitability, LEN-B's ROE is +0.08%, compared to HOV's ROE of +0.04%. Regarding short-term risk, LEN-B is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check HOV's competition here
LEN-B vs SIC Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, LEN-B is priced at $90.88, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas SIC's P/E ratio is 7.11. In terms of profitability, LEN-B's ROE is +0.08%, compared to SIC's ROE of -0.06%. Regarding short-term risk, LEN-B is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SIC's competition here
LEN-B vs UHG Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, UHG has a market cap of 71.8M. Regarding current trading prices, LEN-B is priced at $90.88, while UHG trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas UHG's P/E ratio is -4.36. In terms of profitability, LEN-B's ROE is +0.08%, compared to UHG's ROE of -0.23%. Regarding short-term risk, LEN-B is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check UHG's competition here
LEN-B vs SPHL Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, SPHL has a market cap of 5.4M. Regarding current trading prices, LEN-B is priced at $90.88, while SPHL trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas SPHL's P/E ratio is -20.56. In terms of profitability, LEN-B's ROE is +0.08%, compared to SPHL's ROE of -0.37%. Regarding short-term risk, LEN-B is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SPHL's competition here
LEN-B vs NWHM Comparison June 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, LEN-B is priced at $90.88, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 13.07, whereas NWHM's P/E ratio is N/A. In terms of profitability, LEN-B's ROE is +0.08%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, LEN-B is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NWHM's competition here